David Wasserman Archives
Oct. 11, 2018—It’s possible to increase the permeability of blood vessels and accelerate insulin action in muscle, Vanderbilt researchers have discovered.
Team’s findings could spur new treatments for type 2 diabetes
Sep. 6, 2018—An international research team including scientists from Vanderbilt University has discovered how the diabetes drug metformin blocks glucose production by the liver. The discovery, reported Aug. 27 in the journal Nature Medicine, could lead to development of new ways to treat type 2 diabetes.
Faculty meeting recognizes excellence in education, research and clinical service
May. 24, 2018—During Wednesday’s Spring Faculty Meeting, Jeff Balser, M.D., Ph.D., dean of Vanderbilt University School of Medicine and President and CEO of Vanderbilt University Medical Center, highlighted the medical school’s rising stature among the country’s top-tier institutions.
Voluntary exercise and energy balance
Mar. 23, 2018—Non-exercise physical activity has a measurable energy expenditure, which goes down when animals engage in voluntary exercise, Vanderbilt researchers have discovered.
Study may point to new ways to reverse insulin resistance
Jan. 25, 2018—Researchers at Vanderbilt University have discovered how insulin crosses the capillary endothelium to exit blood vessels and stimulate skeletal muscle cells — a major finding that may lead to new ways to reverse insulin resistance, a hallmark of type 2 diabetes.
15 faculty members elected as AAAS fellows
Nov. 20, 2017—Fifteen Vanderbilt faculty members conducting a range of biomedical and clinical research have been elected fellows of the American Association for the Advancement of Science. Six of the 15 have received funding through the university’s Trans-Institutional Programs initiative, which facilitates research and teaching collaborations across disciplines and are a core pillar of the university’s Academic Strategic Plan.
Phenotyping center a global resource for investigators
Nov. 16, 2017—This summer the Vanderbilt Mouse Metabolic Phenotyping Center (MMPC) began its 17th year of continuous operation and federal support with a $5.5 million, five-year renewal grant from the National Institutes of Health (NIH).
Study spots possible new approach to prevent obesity
Apr. 14, 2016—An international research team that included scientists from Vanderbilt University Medical Center has found a novel way to counteract obesity in mice — by stimulating the growth of blood vessels in fat tissue.
Photo: Mouse Metabolic Phenotyping Center
Jun. 25, 2015—David Wasserman, Ph.D., kicks off Wednesday’s ribbon cutting and open house to celebrate the newly renovated Mouse Metabolic Phenotyping Center (MMPC) on the eighth floor of Light Hall. The center, founded in 2001, provides novel techniques for studying mouse models of diabetes and other metabolic disorders. As measured by the scientific papers that flow out...
Matrix remodeling and insulin resistance
Apr. 10, 2014—The extracellular matrix that surrounds cells plays a role in the development of insulin resistance.
Relaxin combats insulin resistance
Oct. 16, 2013—The hormone relaxin may offer a novel approach for treating diet-induced insulin resistance.
Matrix member key to insulin resistance
Jun. 6, 2013—A component of the extracellular matrix that surrounds cells plays a role in insulin resistance and may be a good therapeutic target.